Pyxis Oncology (PYXS) Earnings Date & Reports

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYXS is expected to report earnings to fall 24.62% to -27 cents per share on November 17

Pyxis Oncology PYXS Stock Earnings Reports

Q3'26

Est.

$-0.28

Q1'26

Est.

$-0.37

Q4'25

Missed

by $0.95

Q3'25

Missed

by $0.01

Q2'25

Beat

by $0.04

The last earnings report on May 14 showed earnings per share of -37 cents, meeting the estimate of -37 cents. With 433.32K shares outstanding, the current market capitalization sits at 256.90M.

View a ticker or compare two or three

PYXS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days